An update today came with strong pleas for Congress to pass $1.9 billion in funding.
The saliva report hints at a possible human-to-human transmission route, and the meningitis report expands the list of possible neuro complications.
Priorities include diagnostic tests, inactivated vaccines, and mosquito-control tools.
The WHO Zika emergency committee, in its 2nd meeting, called for stronger steps.
The WHO has convened its Zika emergency committee for the 2nd time, a 3-day countermeasure meeting begins in Geneva, and a mouse study shows promise for a broad-spectrum antiviral drug.
Research finds 29% of women with Zika have babies with abnormalities as well as evidence that cortical cells in the fetus could be disrupted.
The CDC will host a summit Apr 1, Laos has local transmission, and studies highlight key developments.
Also, Brazil notes more than 200 new suspected microcephaly cases and results of lab experiments in common Culex mosquitoes, while the FDA releases guidance on screening of cells and tissue.
The study from French Polynesia comes as the WHO publishes related guidance.
Researchers put the overall GBS risk at 2.4 for every 10,000 people infected with Zika virus.
